Correlation Between Double Medical and Suzhou Novoprotein

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Double Medical and Suzhou Novoprotein at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Double Medical and Suzhou Novoprotein into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Double Medical Technology and Suzhou Novoprotein Scientific, you can compare the effects of market volatilities on Double Medical and Suzhou Novoprotein and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Double Medical with a short position of Suzhou Novoprotein. Check out your portfolio center. Please also check ongoing floating volatility patterns of Double Medical and Suzhou Novoprotein.

Diversification Opportunities for Double Medical and Suzhou Novoprotein

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Double and Suzhou is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Double Medical Technology and Suzhou Novoprotein Scientific in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Suzhou Novoprotein and Double Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Double Medical Technology are associated (or correlated) with Suzhou Novoprotein. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Suzhou Novoprotein has no effect on the direction of Double Medical i.e., Double Medical and Suzhou Novoprotein go up and down completely randomly.

Pair Corralation between Double Medical and Suzhou Novoprotein

Assuming the 90 days trading horizon Double Medical Technology is expected to generate 2.8 times more return on investment than Suzhou Novoprotein. However, Double Medical is 2.8 times more volatile than Suzhou Novoprotein Scientific. It trades about 0.32 of its potential returns per unit of risk. Suzhou Novoprotein Scientific is currently generating about -0.19 per unit of risk. If you would invest  2,970  in Double Medical Technology on November 4, 2024 and sell it today you would earn a total of  542.00  from holding Double Medical Technology or generate 18.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Double Medical Technology  vs.  Suzhou Novoprotein Scientific

 Performance 
       Timeline  
Double Medical Technology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Double Medical Technology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Double Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Suzhou Novoprotein 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Suzhou Novoprotein Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Double Medical and Suzhou Novoprotein Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Double Medical and Suzhou Novoprotein

The main advantage of trading using opposite Double Medical and Suzhou Novoprotein positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Double Medical position performs unexpectedly, Suzhou Novoprotein can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Suzhou Novoprotein will offset losses from the drop in Suzhou Novoprotein's long position.
The idea behind Double Medical Technology and Suzhou Novoprotein Scientific pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format